Health Trials

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

ConditionsBreast CarcinomaEsophageal CarcinomaGenitourinary System CarcinomaHead and Neck CarcinomaHematopoietic and Lymphoid Cell NeoplasmLung CarcinomaMalignant Central Nervous System NeoplasmMalignant Digestive System NeoplasmMalignant Solid Neoplasm
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center

About this trial

This study collects information on the side effects of proton therapy and detailed information on the proton therapy treatment plan itself. This may help researchers develop methods to predict the risk of side effects for future patients and learn the long-term benefit of proton therapy.

Eligibility criteria

Qualifiers

All patients scheduled for radiation treatment with protons at UTMDACC are eligible for this protocol

Patients must sign a study-specific consent form prior to study entry

Disqualifiers

Patients who are unable or unwilling to attend the required periodic follow-ups either at M.D. Anderson or at a different site

Trial design

Treatments tested in this trial

  • Quality-of-Life Assessment
  • Questionnaire Administration

Treatment groups

5,000 Participants
are divided into 1 treatment group

Sponsors and collaborators

M.D. Anderson Cancer Center

Lead sponsor

Source ClinicalTrials.gov